Perioperative docetaxel, cisplatin, and 5-fluorouracil compared to standard chemotherapy for resectable gastroesophageal adenocarcinoma-Reference-Cited by-同舟云学术

Perioperative docetaxel, cisplatin, and 5-fluorouracil compared to standard chemotherapy for resectable gastroesophageal adenocarcinoma

Published:2017-01 Issue:1 Volume:43 Page:218-225
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology (EJSO)
language:en
Short-container-title:European Journal of Surgical Oncology (EJSO)

Author:

Kim S.^ORCID,Paget-Bailly S.^ORCID,Messager M.,Nguyen T.,Mathieu P.,Lamfichekh N.,Fein F.,Fratté S.^ORCID,Cléau D.,Lakkis Z.^ORCID,Jary M.,Sakek N.,Jacquin M.,Foubert A.^ORCID,Bonnetain F.,Mariette C.,Fiteni F.,Borg C.

Publisher

Elsevier BV

Subject

Oncology,General Medicine,Surgery

Reference28 articles.

1. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer;Cunningham;N Engl J Med,2006

2. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial;Ychou;J Clin Oncol,2011

3. Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 study group;Van Cutsem;J Clin Oncol,2006

4. Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial;Ford HER;Lancet Oncol,2013

5. Quality of life with docetaxel plus cisplatin and fluorouracil compared with cisplatin and fluorouracil from a phase III trial for advanced gastric or gastroesophageal adenocarcinoma: the V-325 study group;Ajani;J Clin Oncol,2007

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multidisciplinary treatment of advanced cervical esophageal adenocarcinoma derived from a gastric inlet patch: A case report;Oncology Letters;2024-01-25

2. Preferred neoadjuvant therapy for gastric and gastroesophageal junction adenocarcinoma: a systematic review and network meta-analysis;Gastric Cancer;2022-06-15

3. Predicting pathological response and overall survival in locally advanced gastric cancer patients undergoing neoadjuvant chemotherapy: the role of PET/computed tomography;Nuclear Medicine Communications;2022-01-17

4. Neoadjuvant chemoradiotherapy improves survival in locally advanced adenocarcinoma of esophagogastric junction compared with neoadjuvant chemotherapy: a propensity score matching analysis;BMC Surgery;2021-03-17

5. The postoperative part of perioperative chemotherapy fails to provide a survival benefit in completely resected esophagogastric adenocarcinoma;Surgical Oncology;2020-06